Pathobiology of liver fibrosis: a translational success story

YA Lee, MC Wallace, SL Friedman - Gut, 2015 - gut.bmj.com
Reversibility of hepatic fibrosis and cirrhosis following antiviral therapy for hepatitis B or C
has advanced the prospect of developing antifibrotic therapies for patients with chronic liver …

[HTML][HTML] The homeostatic force of ghrelin

S Yanagi, T Sato, K Kangawa, M Nakazato - Cell metabolism, 2018 - cell.com
Ghrelin, a gastric-derived acylated peptide, regulates energy homeostasis by transmitting
information about peripheral nutritional status to the brain, and is essential for protecting …

[HTML][HTML] Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update

GÖ Elpek - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
There have been considerable recent advances towards a better understanding of the
complex cellular and molecular network underlying liver fibrogenesis. Recent data indicate …

[HTML][HTML] The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Y Watanabe, A Tsuchiya, S Terai - Clinical and molecular …, 2021 - ncbi.nlm.nih.gov
Cirrhosis is a chronic condition that can lead to liver failure. Currently, the viable option for
decreasing mortality is liver transplantation. However, transplant surgery is highly invasive …

[HTML][HTML] Molecular mechanism contributing to malnutrition and sarcopenia in patients with liver cirrhosis

F Meyer, K Bannert, M Wiese, S Esau… - International journal of …, 2020 - mdpi.com
Liver cirrhosis is frequently accompanied by disease-related malnutrition (DRM) and
sarcopenia, defined as loss of skeletal muscle mass and function. DRM and sarcopenia …

[HTML][HTML] Pathophysiology of NAFLD and NASH in experimental models: the role of food intake regulating peptides

L Kořínková, V Pražienková, L Černá… - Frontiers in …, 2020 - frontiersin.org
Obesity, diabetes, insulin resistance, sedentary lifestyle, and Western diet are the key factors
underlying non-alcoholic fatty liver disease (NAFLD), one of the most common liver diseases …

Current status of novel antifibrotic therapies in patients with chronic liver disease

M Cohen-Naftaly, SL Friedman - Therapeutic advances in …, 2011 - journals.sagepub.com
Fibrosis accumulation is a dynamic process resulting from a wound-healing response to
acute or chronic liver injury of all causes. The cascade starts with hepatocyte necrosis and …

[HTML][HTML] The role of innate immunity in alcoholic liver disease

LE Nagy - Alcohol research: current reviews, 2015 - ncbi.nlm.nih.gov
The innate immune system represents the first-line response to invading microbes, tissue
damage, or aberrant cell growth. Many of the proteins and cells involved in innate immunity …

[HTML][HTML] Herbal remedies for liver fibrosis: A review on the mode of action of fifty herbs

U Latief, R Ahmad - Journal of traditional and complementary medicine, 2018 - Elsevier
Liver fibrosis is a dynamic pathological condition which can be slowed down in its initial
phases. Without proper clinical management of fibrosis, progressive liver damage may lead …

Autophagy: a new target for nonalcoholic fatty liver disease therapy

Y Mao, F Yu, J Wang, C Guo, X Fan - Hepatic medicine: evidence …, 2016 - Taylor & Francis
Nonalcoholic fatty liver disease (NAFLD) has gained importance in recent decades due to
drastic changes in diet, especially in Western countries. NAFLD occurs as a spectrum from …